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Abstract
Background—Polybrominated diphenyl ethers (PBDEs) are persistent flame retardants found in
the environment, in household dust, and in humans. Breast feeding is a prominent route of
exposure in infancy. PBDEs adversely affect neurodevelopment in animals. Here, we estimate
associations between PBDEs in breast milk and behavior and cognitive skills in children at 36
months of age.
Methods—We prospectively studied 304 mothers and their children. We measured PBDEs in
breast milk collected at 3 months postpartum. At 36 months, we measured child behavior with the
parent-rated Behavioral Assessment System for Children 2 (n = 192), and cognitive skills with the
Mullen Scales of Early Learning (n = 184). We analysed data with robust regression.
Results—We detected BDE-28, −47, −99, −100, and −153 in >70% of milk samples. For each
congener, the highest quartile of breast milk PBDE concentration, versus the lowest, was
associated with more anxious behavior, after confounder adjustment. Select congeners were
associated with increased withdrawal (BDE-28) and improved activity of daily living skills
(BDE-153). Cognitive skills tended to be positively associated with PBDEs, especially language
and fine motor skills. However, most estimates were imprecise.
Conclusions—Here, lactational PBDE exposure was modestly and imprecisely associated with
anxiety and withdrawal, but was also associated with improved adaptive and cognitive skills.
Positive factors associated with breast feeding may have mitigated some of the hypothesized
adverse neurodevelopmental outcomes associated with PBDEs. Further research is needed to
inform our understanding of PBDE neurotoxicity and how sources of exposure might confound
neurodevelopmental studies.
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INTRODUCTION
Polybrominated diphenyl ethers (PBDEs) are high production-volume chemicals widely
used as flame retardants in electronic devices, textiles, and the polyurethane foam used in
furniture.1–4 PBDEs are additive flame retardants, meaning that they are not chemically
bound to products and therefore have the potential to leach out of materials over time.5 As
such, several PBDE congeners are ubiquitous in the environment.6–8 PBDEs have been
broadly detected in humans, including human breast milk.9–11 Exposure sources may
include indoor dust and possibly, to a lesser extent, contaminated food; however, the degree
to which various exposure pathways contribute to human exposure remains unclear.8, 12–14
Because PBDEs are highly lipophilic, they concentrate in breast milk and can be ingested by
nursing infants.1 Animal studies suggest that early life PBDE exposure may adversely affect
thyroid function and behavioral development, specifically hyperactivity and habituation, as
well as cognitive development, including learning and memory (reviewed in Costa and
Giordano15). However, little is known about the health risks to exposed infants. Studies of
prenatal PBDE exposures have suggested some adverse neurodevelopmental effects,
including lower mental and physical development scores at 12–48 and 72 months,16 but
findings are not entirely consistent across studies.17, 18 Furthermore, few studies have
investigated associations between postnatal exposures and neurodevelopment. Of the studies
that have examined postnatal breast milk concentrations of PBDEs and neurologic
outcomes, assessments are limited to very young children (< 18 months) and reported breast
milk PBDE levels are low, with limited relevance to mothers and infants in the United
States.19, 20
Previously, we reported that breast milk PBDE concentrations were associated with
externalizing behavior problems in breast-fed children at age 30 months.21 Here, we have
investigated the association between PBDE exposures through breastfeeding and both
behavioral and cognitive development at 36 months of age in a cohort of children followed
in central North Carolina.
METHODS
Study Sample
The Pregnancy, Infection and Nutrition (PIN) Babies Study included children born to central
North Carolina women who had participated in the PIN3 and PIN Postpartum studies.22
Births occurred from January 2004 to December 2006. The PIN studies recruited pregnant
women of less than 20 weeks of gestation who were receiving prenatal care at University of
North Carolina Hospitals. Sixty-four percent of eligible women participated in PIN during
pregnancy and 73% of eligible PIN participants continued into PIN Postpartum, where
eligibility was defined as having a singleton infant without major birth defects.9 PIN
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mothers completed several self-administered questionnaires, two phone interviews during
pregnancy, and one in-hospital questionnaire after delivery. For PIN Babies, three inhome
interviews were conducted at 3, 12, and 36 months postpartum regarding the participants’
health and lifestyle during and after pregnancy. Rarely, interviews were conducted by phone
if a home visit could not be performed. The protocols of all PIN studies have been approved
by the Institutional Review Board of the University of North Carolina at Chapel Hill, and all
participating mothers gave written informed consent. The involvement of the Centers for
Disease Control and Prevention (CDC) laboratory was determined not to constitute
engagement in human subjects research.
Among the 585 participants of the PIN Babies Study, 304 mothers were still lactating at 3
months postpartum and were willing to provide a breast milk sample. Participating mothers
followed written instructions to pump both breasts at approximately 10 o’clock in the
morning of the scheduled interview. They gently mixed milk and used a plastic pipette to
transfer milk into three 1.5 ml tubes, which were stored in the freezer until interviewers
arrived. Samples were then transported on ice to −80 ºC storage freezers.
Outcome Assessment
Behavioral development was assessed with the parent rating scale for preschool-age children
(PRS-P) of the Behavior Assessment System for Children, 2nd Edition (BASC-2),23 which is
designed to measure both negative (Clinical) and positive (Adaptive) dimensions of
behavior and personality. Parents, unaware of exposure status, completed and returned
questionnaires by mail or at the 36-month home visit. The preschool parent scale for
children ages 2–5 years includes 8 Clinical Scales and 4 Adaptive Scales (listed in Figure 1).
Together, these scales combine into 4 Composite Scales: Externalizing Problems
(hyperactivity and aggression), Internalizing Problems (anxiety, depression, somatization),
Behavioral Symptoms Index (hyperactivity, aggression, depression, atypicality, withdrawal
and attention problems), and Adaptive Skills (all Adaptive Scale items). Higher scores on
Clinical Scales reflect more problematic (negative) behaviors, while higher scores on
Adaptive Scales reflect more adaptive (positive) behaviors. Each raw scale and composite
score was converted to an age-standardized T score with a mean of 50 and a standard
deviation (SD) of 10. The validity of each parent questionnaire was evaluated with the
BASC-2 internal measure, the F-Score, in which higher scores suggest more questionable
results. One subject with an F-score of 2 was excluded from analyses; all included subjects
had F-scores of 0 or 1.
Cognitive development was assessed with the Mullen Scales of Early Learning (MSEL), a
comprehensive individual assessment for infants and young children. The MSEL is designed
to assess five functionally distinct but related developmental scales (visual perception,
expressive and receptive language, and fine and gross motor skills). The first four of these
scales are combined to provide an early learning composite that reflects general
intelligence.24 Trained staff administered the MSEL in the child’s home at 36 months of
age, without knowledge of the child’s exposure status.25 The MSEL has been standardized
on a large sample of children in the United States, and it has well-established validity and
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reliability.24 Each scale produces age-adjusted T-scores with a mean of 50 and an SD of 10;
the early learning composite score is age-standardized at a mean of 100 and an SD of 15.
Exposure measurement
We analysed breast milk samples for 10 PBDE congeners (−17, −28, −47, −66, −85, −99,
−100, −153, −154, −183) according to the existing methodology at the Organic Analytic
Toxicology Branch of the National Center for Environmental Health at CDC,26 as described
previously.9 We express all concentrations reported here on a lipid normalized basis (ng/g
lipid). We do so to reduce the variability in lipid content between different milk samples and
inhomogeneity originating from lipid separation during freezing of the samples. Our a priori
criterion was to include only PBDEs detected in > 70% of samples in our analyses. As such,
we included BDE −28, −47, −99, −100, −153, all of which were actually detected in ≥ 90%
of samples. Concentrations of these congeners below the limit of detection (LOD) have been
assigned a value of the LOD/√2. BDEs −28, −47, −99, −100, and −153 were also summed to
produce a cumulative measure (ΣPBDE).
Statistical Analysis
We analysed data by using SAS version 9.2 (SAS Institute Inc., Cary, NC). We examined
crude associations between quartiles of natural log-transformed PBDE concentrations and
outcomes (age-adjusted BASC-2 and MSEL T scores) to assess the linearity of the exposure
and outcome relationships. The mean T scores across quartiles did not support a linear
relationship for most comparisons; therefore, we modeled all milk PBDE concentrations as
quartiles, defined by using all available samples (n = 304) (Table 3). In order to yield
conservative estimates in the presence of influential outliers and the slight skewness in some
outcome distributions, we used multivariable robust regression (M estimation) to estimate
the mean difference in T scores for each BASC-2 and MSEL sub- and composite scale
across quartiles of PBDE −28, PBDE-47, PBDE-99, PBDE-100, PBDE-153, and ΣPBDE
using the 1st quartile (< 25th percentile) as the referent for all models (PROC
ROBUSTREG).27
We included covariates as confounders if they had been associated with both lactational
PBDE exposure and child neurodevelopment in relevant literature. These covariates
included the child’s sex, maternal age at start of pregnancy (≤ 25, 26–30, 31–35, >35
[BASC-2]; continuous years [MSEL]), parity (0 or ≥ 1), education (< or ≥ 16 years),
maternal race (nonwhite or white), breastfeeding duration (< or ≥ 10 months), postpartum
income (≤ or > $35,000/year), breast milk omega 3 fatty acid concentration (summed
docosahexaenoic acid (DHA) and eicosapentaenoic acid (EPA), quartiles), and fatty acid
assay batch (1 or 2). We present results adjusted for these factors as our primary results. To
assess the influence of the parenting and home environment on the association, we also ran
models that adjusted for modified Home Observation for Measurement of the Environment
(HOME) scores,28 composed of HOME score items ascertained by interview only, and
maternal stress, evaluated by the Perceived Stress Scale,29 along with the covariates listed
above. In addition to our primary results, we describe results that were affected by these
additional adjustment factors, as warranted. Continuous variables were categorized as
needed when distributional or linearity assumptions were not met.
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The characteristics of the 304 mothers who provided milk samples at 3 months postpartum
have been described previously.9, 25 Of these, 184 (61%) of their children completed MSEL
evaluations and maternal interviews in their home and 192 (63%) returned valid BASC-2
forms (Table 1), 16% of whom completed maternal interviews by telephone.
In general, this study sample included mothers who were mostly > 25 years of age, were
college educated, were non-smokers (95%), and were white. A majority of infants were
breastfed for at least 10 months. Compared to families who were lost to follow-up, mothers
who completed the BASC-2 and whose children completed the MSEL were more likely to
be white; BASC-2 mothers were also slightly older than those lost to follow-up. PIN
subjects generally performed similarly to, or slightly better than, the normative population
on the BASC-2 and MSEL assessments; most of the BASC-2 and MSEL subscale T scores
were near the expected value of 50, while scores for most BASC-2 Adaptive subscales,
MSEL Expressive Language, and MSEL Visual Reception were slightly elevated (Table 2).
PBDE concentrations (Table 3) were correlated across congeners (r = 0.48 – 0.92), and they
did not differ between retained participants and participants lost to follow-up (not shown).
Overall, associations between mothers’ milk PBDE concentrations and children’s BASC-2
scores were small and imprecisely estimated (Figure 1, supplemental Table 1). Within the
Clinical Scales, higher PBDE breast milk concentrations were most consistently associated
with higher (more problematic) anxiety scores (adjusted β, (βadj) [95% confidence interval
(CI)] for 4th Quartile vs. 1st Quartile: BDE-28: βadj = 3.9 [95% CI 0.2, 7.6]; BDE-47: βadj =
2.7 [95% CI −1.0, 6.4]; BDE-99: βadj =4.2 [95% CI 0.6, 7.9]; BDE-100: βadj = 4.1 [95% CI
0.4, 7.8]; BDE-153: βadj = 2.9 [95% CI −1.0, 6.7]). Withdrawal scores also tended to
increase with increasing milk concentration, particularly for BDE-28 (βadj = 4.1 [95% CI
0.6, 7.7]). With respect to externalizing behaviors, associations between mothers’ milk
PBDE concentration and children’s aggression and hyperactivity were generally null, with
only suggested positive associations observed for aggression and the highest quartiles of
BDE-99 and 153 (βadj = 2.0 [95% CI −1.0, 5.0] and βadj = 1.9 [95% CI −1.4, 5.1],
respectively).
Within the Adaptive Scales, higher parent ratings on child competence in activities of daily
living skills corresponded to increasing BDE-153 milk concentration, suggestive of a
possible linear dose-response. Other Adaptive Scale associations tended to occur in the 2nd
or 3rd milk concentration quartiles, but these associations varied with respect to magnitude
and direction. No notable associations were observed among the BASC-2 Composite Scales.
As expected given the correlation across congeners, associations between BASC-2 measures
and ΣPBDE concentrations followed similar patterns as those for the individual congeners,
as described above (Supplemental Table 3; e.g.,4th Quartile vs. 1st Quartile, anxiety: βadj =
2.3 [95% CI −1.3, 5.9]; withdrawal: βadj = 2.4 [95% CI −1.0, 5.0]; activities of daily living:
βadj = 3.3 [95% CI −0.3, 6.9]). Furthermore, ordinary least squares regression did not yield
substantially different associations or greatly improve precision over robust regression.
Additional adjustment for modified HOME scores and maternal stress was associated with
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small fluctuations in point estimates compared to the original model, but no there was
change in the conclusions for most comparisons. Of note, suggested associations between
high BDE-153 concentrations and somatization, and between high BDE-99 concentrations
and aggression (as reflected in Figure 1), were attenuated when these additional adjustment
factors were included in the model: BDE-153 and somatization: βadj = −2.2 [95% CI 0=
−5.7, 1.2]; BDE-99 and hyperactivity: βadj = 1.2 [95% CI −1.9, 4.3] (highest vs. lowest
quartiles of breast milk concentrations).
Estimated associations between PBDEs and MSEL scores were similarly small and
imprecise, but were generally in a positive direction (Figure 2, supplemental Table 2).
Across all BDE congeners, the highest milk concentration quartile, compared to the lowest,
was associated with adjusted mean T score increases (βadj [95% CI]) ranging from 1.6 [95%
CI −2.3, 5.5] to 4.0 [95% CI 0.4, 7.7] for expressive language; 3.2 [95% CI −1.1, 7.5] to 4.1
[95% CI −0.2, 8.4] for receptive language; 1.7 [95% CI −4.0, 7.3] to 4.2 [95% CI −1.4, 9.8]
for visual reception; and 3.7 [95% CI −2.5, 9.8] to 6.9 [95% CI 0.9, 12.9] for fine motor.
Higher point estimates were suggested in MSEL composite scores as well. Additional
adjustment for modified HOME score and maternal stress did not attenuate associations;
many point estimates actually increased slightly with additional adjustment. As observed
with the BASC-2, associations for ΣPBDE concentrations did not differ from those observed
for individual congeners (Supplemental Table 4).
DISCUSSION
In this study, concentrations of PBDEs in breast milk samples at 3 months were not strongly
associated with most behavioral and cognitive outcomes in children at 36 months of age,
including hyperactivity and aggression. However, despite limited precision, we did observe
suggestive patterns of association for other outcomes, both positive and negative. For
example, the highest concentration quartile for most congeners was associated with
increased anxiety as assessed by the BASC-2, as well as with improved language and fine
motor skills in the MSEL cognitive assessment. Congeners were variably associated with
increased withdrawal (BDE-28) and improved activities of daily living (BDE-153). The
ΣPBDE measure yielded results that were similar to those obtained from the individual
congeners. No single congener appeared to be more strongly associated with outcomes than
the others, but because all congeners were highly correlated, it is difficult to disentangle
individual associations.
Neurotoxicological studies of BDE-47, −99, and −153 in rodents have frequently reported
hyperactivity30–32 and altered habituation33–35 in association with a range of pre- and
postnatal PBDE exposures. A previous study of PBDEs and child behavior reported
associations between prenatal maternal serum concentrations of BDE-47, −99, and −100 and
impaired attention, along with improved internalizing and externalizing behaviors.18 An
association between cord blood concentrations (BDE-28, −99 and ΣBDEs) and delays in
adaptive behavior has also been reported.17 Previously, we reported that lactational PBDE
concentrations were positively associated with increased externalizing behavior problems,
specifically including activity, impulsivity, aggression, and defiance, as well as modestly
increased anxiety at age 30 months.21 Here, we did not find evidence that associations with
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externalizing behaviors persisted at 36 months. We did, however, observe associations
between PBDEs and anxiety. We also observed suggestive associations between PBDEs and
increased withdrawal. These traits collectively—anxiety in particular—may be consistent
with reports of impaired habituation in animal studies, described in part as reduced activity
in the early stages of exposure to new surroundings.15 The effect of PBDEs on habituation
capabilities in animal studies appears to worsen with increasing age.34
Some animal studies have also suggested that PBDEs may cause cognitive impairment,
specifically related to learning, memory, and visual discrimination,34, 36, 37 while others
have shown no effect on learning and attention.36, 38 Small epidemiologic studies have
recently reported on cognitive effects of early life exposures to PBDEs, also with
inconsistent results. Cord blood PBDEs have been positively associated with cognitive
function in 8–12 month infants (BDE-99, Σ BDEs) (n = 36),17 but they have not been
associated with cognitive function at age 4 years (BDE-47) (n = 88).39 Cord blood
concentrations have also been strongly negatively associated with developmental indices
and IQ at ages 12–72 months (BDE-47, 99, 100) (n = 96–118).16 BDE-153 concentrations in
prenatal maternal serum have been associated with decreased verbal memory at age 5–6
years (n = 62), but other congeners and cognitive measures, including IQ, were not so
associated.18
Because most previous studies have measured PBDE concentrations in maternal serum or
cord blood, we cannot directly compare our breast milk PBDE concentrations with
concentrations reported in the studies described above. However, we have previously
demonstrated that the breast milk PBDE concentrations in our study are comparable to or
slightly higher than concentrations reported in other exposure-based studies of breast milk in
the United States.9 To our knowledge, these other small U.S. cohorts have not examined
neurodevelopmental outcomes in relation to breast milk PBDE exposure, but two recent
studies based in Taiwan (n = 70) and Spain (n = 290) have assessed postnatal breast milk
PBDE concentrations and cognitive outcomes.19, 20 In both of these studies, breast milk
PBDE concentrations were at least an order of magnitude lower than in our study (e.g.,
median BDE-47 (ng/g lipid): 27.7 (PIN); 0.475 (Taiwan);19 0.56 (Spain)20). Most of the
PBDE congeners we examined were not associated with cognition in these studies, with the
exception that BDE-100 was positively correlated with language scores in 8–12 month
infants (p = 0.048; median BDE-100: 0.172 ng/g lipid).19 However, both reported negative
cognitive outcomes in association with BDE-209, a congener we were unable to measure.
Along with the congeners and matrix (serum/cord blood vs. breast milk) used for exposure
assessment, inconsistencies between the present study and previous studies of
PBDEs 16, 18–20, 39 may be attributable to several methodological factors, including
differences in the timing of measurement (prenatal vs. postnatal) and in the age at
assessment, along with the variability in how diverse assessment instruments characterize
specific domains of behavior and cognition. Differences may also be attributed to cohort
characteristics or residual confounding. In our study, all women were breastfeeding at 3
months postpartum as a condition of inclusion, and most were highly educated. It is possible
that adverse effects of PBDE exposure on cognitive development may have been mitigated
by the positive effects of prolonged breastfeeding or by residual socioeconomic factors. Our
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results may also have been influenced by a positive unmeasured confounder if PBDE
exposure was associated with an environmental factor that also produced increased
stimulation in early childhood. Alternatively, the strongly adverse outcomes associated with
PBDE exposures described by Herbstman et al.16 may have been modified or confounded by
other negative exposures, stresses, or unique susceptibilities associated with temporal and
geographic proximity to the September 11, 2001 attack, an event upon which study
enrollment was based. We adjusted for the HOME score and maternal stress as markers of
how maternal characteristics may influence the child’s development, which did not
appreciably change results. However, in interpreting results from this literature, we must
consider that a mother’s own behavioral traits may affect her child’s development, as well as
how she completes self-administered questionnaires.
Our study is one of the few to assess postnatal PBDE exposures from concentrations in
breast milk, one of the most prominent sources of early life PBDE body burden. This single
measure, however, prevents us from investigating the potential influence of PBDEs on in
utero brain development, particularly because PBDE partitioning between maternal serum,
the placenta, and breast milk is not uniform by congener.40 Those studies that most strongly
suggest adverse developmental effects are those that characterize prenatal exposures.
Despite small sample size in these studies, their findings may suggest that the prenatal
period is uniquely susceptible. Our study is strengthened by the fact that it is one of the
largest epidemiologic studies to assess developmental impacts of PBDE exposures.
However, it was still subject to imprecise effect estimation, and was not adequately powered
to assess sex-specific effects that have been suggested in some animal studies.41
CONCLUSION
In general, the results of our study do not suggest strong adverse associations between breast
milk PBDE concentrations and behavioral and cognitive outcomes in children at 36 months
of age. While we did observe modest associations between PBDEs and increased anxiety
and withdrawal, we also observed associations between PBDEs and improvement in certain
adaptive behaviors and most cognitive outcomes. These results were imprecisely estimated
and few reached statistical significance, and therefore should be interpreted cautiously.
Since PBDEs are persistent compounds with demonstrated neurotoxicity, our results do not
preclude the need for further monitoring of neurodevelopmental effects as children age.
Future studies should also investigate both prenatal and postnatal exposures as they relate to
neurodevelopment, as well as further elucidate sources of PBDE exposure. However, with
respect to the congeners measured in this sample, lactational PBDE exposures do not appear
to challenge the extensive benefits of breastfeeding.
Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
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Mean difference estimates by quartile of PBDE congener (1st quartile, referent) for the BASC-2, adjusted for sex, parity,
maternal education, maternal race, breastfeeding duration, income, maternal age, fatty acids (quartiles), and fatty acid analysis
batch.
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Mean difference estimates by quartile of PBDE congener (1st quartile, referent) for the MSEL, adjusted for sex, parity, maternal
education, maternal race, breastfeeding duration, income, maternal age, fatty acids (quartiles), and fatty acid analysis batch.
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Table 2
Distribution of BASC-2 and MSEL scores among PIN Babies participants
Instrument Subscale Mean (SD) Range
BASC-2 (n = 192)
 Clinical Scales
  Aggression 47 (8) 34–69
  Anxietya 51 (9) 36–82
  Attention Problems 48 (7) 29–73
  Atypicality 49 (8) 39–75
  Depression 48 (7) 32–71
  Hyperactivity 49 (7) 34–75
  Somatization 48 (8) 33–79
  Withdrawal 48 (9) 30–82
 Adaptive Scales
  Activities of Daily Living 49 (9) 29–72
  Adaptability 54 (8) 36–70
  Functional Communication 53 (8) 32–74
  Social Skills 55 (7) 36–73
 Composite Scales
  Externalizing Problems 48 (7) 36–74
  Internalizing Problemsa 49 (8) 32–69
  Adaptive Skills 53 (7) 33–70
  Behavioral Symptoms Index 48 (7) 31–65
MSEL (n = 184)
  Expressive Languagea 57 (11) 20–76
  Receptive Languagea 53 (11) 20–76
  Fine Motor 49 (14) 20–80
  Visual Receptiona 57 (14) 20–80
  Compositea 109 (20) 49–148
BASC-2: Behavior Assessment System for Children, 2nd Edition; MSEL: Mullen Scales of Early Learning
a
missings: BASC-2 Anxiety, n = 1; BASC-2 Internalizing Problems, n = 1; MSEL Expressive Language, n = 7; MSEL Receptive Language, n = 4;
MSEL Visual Reception, n = 5; MSEL Composite, n = 8.
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